Literature DB >> 15687003

Simple determination of riluzole in rat brain by high-performance liquid chromatography and spectrophotometric detection.

Adriana Maltese1, Francesco Maugeri, Filippo Drago, Claudio Bucolo.   

Abstract

A simple method was developed for separation and quantification of riluzole in rat brain. The analyses were performed by high-performance liquid chromatography using a C18 reversed-phase column (Hypersil ODS) with UV detection at 264 nm. The mobile phase consisted of methanol-water containing 1% triethylamine adjusted with orthophosphoric acid to pH 3.2. The retention time was 8.6 min. A simple liquid-liquid extraction with ethyl acetate was used to obtain riluzole from brain samples. The limit of quantification was 10 ng/g. The recovery was about 80%. The relationship between peak areas and concentrations was linear over the range between 0.01 and 0.8 microg/g, with r2 value over 0.99. The assay provided good reproducibility and accuracy and proved to be suitable for pharmacokinetic studies of riluzole.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15687003     DOI: 10.1016/j.jchromb.2004.11.053

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  3 in total

1.  Increased survival and reinnervation of cervical motoneurons by riluzole after avulsion of the C7 ventral root.

Authors:  Sándor Pintér; Balázs Gloviczki; András Szabó; Gábor Márton; Antal Nógrádi
Journal:  J Neurotrauma       Date:  2010-12       Impact factor: 5.269

2.  The dual cyclooxygenase/5-lipoxygenase inhibitor licofelone attenuates p-glycoprotein-mediated drug resistance in the injured spinal cord.

Authors:  Jennifer N Dulin; Meredith L Moore; Raymond J Grill
Journal:  J Neurotrauma       Date:  2013-01-23       Impact factor: 5.269

3.  Stability-indicating Method for the Estimation of Riluzole in Tablets.

Authors:  T Neeha; P Bhargavi; A Aruna Jyothi; G Devalarao; B N Nalluri
Journal:  Indian J Pharm Sci       Date:  2013-05       Impact factor: 0.975

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.